Left unaddressed, non-alcoholic fatty liver disease (NAFLD) will continue to have substantial
health, economic and social implications. To address the challenge, a paradigm shift is …

Non-alcoholic fatty liver disease (NAFLD) has become one of the most frequent chronic liver
diseases in the Western society and its prevalence is likely to rise even further. An …

This patient guideline is intended for all patients at risk of or living with non-alcoholic fatty
liver disease (NAFLD). NAFLD is the most frequent chronic liver disease worldwide and …

We present here the first update of the 2013 EFSUMB (European Federation of Societies for
Ultrasound in Medicine and Biology) Guidelines and Recommendations on the clinical use …

Liver fibrosis is characterized by the accumulation of extracellular matrix proteins such as
collagen in the liver interstitial space. All causes of chronic liver disease may lead to fibrosis …

Methods We developed a Markov model to compare the strategies of screening and
treatment versus no screening and treatment of nonalcoholic steatohepatitis (NASH) in …

Abstract Introduction Non-Alcoholic Steatohepatitis (NASH) is a chronic, progressive
disease characterized by fatty liver and liver cell injury, advancing to fibrosis, cirrhosis and …

Objectives To perform head-to-head comparisons of the feasibility and diagnostic
performance of transient elastography (TE), point shear-wave elastography (pSWE), and …

This review evaluates the ability of the fibrosis index based on four factors (FIB-4) identifying
fibrosis stages, long-time prognosis in chronic liver disease, and short-time outcomes in …

Background Screening for nonalcoholic fatty liver disease (NAFLD) is suboptimal due to the
subjective interpretation of US images. Purpose To evaluate the agreement and diagnostic …